A carregar...
Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
INTRODUCTION: Breast cancer is the most common cancer affecting women. Many patients ultimately progress to metastatic disease and optimal management of this disease remains a significant therapeutic challenge. Lapatinib, a dual tyrosine kinase inhibitor, is in clinical development for treatment of...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2005
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3321658/ https://ncbi.nlm.nih.gov/pubmed/22500146 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|